WebIonis Pharmaceuticals, Inc. beschäftigt sich mit der Entdeckung und Entwicklung von Ribonukleinsäure (RNA)-gezielten Therapeutika. Das Unternehmen konzentriert sich in erster Linie auf die Bereiche Herz-Kreislauf und Neurologie. Zu den Produkten des Unternehmens gehören SPINRAZA, TEGSEDI und WAYLIVRA. Web20 apr. 2024 · Ionis Pharmaceuticals, Inc. announced that its partner Roche, also known as Genentech in the United States, has completed enrollment for GENERATION HD1, a global Phase 3 study evaluating the efficacy and safety of tominersen, an investigational antisense therapy for people living with Huntington's disease.
IONIS HOTEL (Peratata, Griekenland) - foto
WebIONIS PHARMACEUTICALS, INC. : Veränderung des Consensus und Kursziel der Analysten der Aktie IONIS PHARMACEUTICALS, INC. IONS US4622221004 Berne Stock Exchange Web23 feb. 2024 · IONIS APO(a)-LRx was, therefore, investigated in a phase 1/2a first-in-man trial using lower doses compared to IONIS APO-Rx trials, and resulting in even better effectiveness (66% in the 10 mg group, 80% in the 20 mg group, and 92% in the 40 mg group (p = 0.0007 for all vs. placebo) at day 36. north olmsted ohio zip codes
IONIS PHARMACEUTICALS, INC. : Konsensus der Analysten und …
WebThe Ionis Hotel has hand-picked the essentials for a relaxing getaway – a lounger-lined pool, a breakfast buffet, and a peaceful location. This place is nestled in a small village in the Kefalonian countryside. You’ve got three beaches around 10 minutes’ drive away – including a couple of sandy numbers with glass-clear water. WebIonis is focused on delivering RNA-targeted therapeutics with transformational potential. Our antisense oligonucleotide drug discovery platform has transformed the lives of patients with devastating diseases, including SMA, hATTR, and FCS. We have the potential to treat many additional diseases where other therapeutic approaches have proven ... Web24 jul. 2024 · Ionis Pharmaceuticals, Inc. ClinicalTrials.gov Identifier: NCT04030598 Other Study ID Numbers: ISIS 721744-CS2 2024-001044-22 ( EudraCT Number ) First Posted: July 24, 2024 Key Record Dates: Results First Posted: September 28, 2024: Last Update Posted: April 3, 2024 Last Verified: March 2024 north olmsted ordinances